About This Event
BillionToOne (Nasdaq: BLLN), molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Dr. Oguzhan Atay, CEO & Co-Founder and Dr. David Tsao, CTO & Co-Founder, ring the Opening Bell.